Success Stories: In Just 1 Month, 22 days, an Indian Research Scientist in the Field of Public Health Secures NIW Case Approval with the Help of Our Expert Team

Client’s Testimonial:

“Thank you for your notice. Your services have been exceptional.”

On March 10^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Research Scientist in the Field of Public Health (Approval Notice).

General Field: Public Health

Position at the Time of Case Filing: Research Scientist

Country of Origin: India

State of Residence at the Time of Filing: New York

Approval Notice Date: March 10^th, 2025

Processing Time: 1 month, 22 days (Premium Processing Requested)

Case Summary:

A research scientist recently contacted us to request assistance in filing a National Interest Waiver (NIW) petition. At North America Immigration Law Group, we have a proven history of successfully representing clients before USCIS. Our extensive experience allows us to craft petitions that align effectively with current immigration requirements.

Upon reviewing her credentials, we found that our client holds an M.P.H. in sociomedical sciences and has established an impressive publication record. Specifically:

As an expert in the field of public health, her proposed endeavor is to continue her research on developing and implementing state-of-the-art digital health platforms for managing and preventing cardiovascular diseases in adults, using qualitative and mixed-method public health research approaches, to provide healthcare providers and patients with effective tools for improving cardiovascular health outcomes and quality of life.
Specifically, she will design, administer, and analyze qualitative and mixed-method research to randomized control trials to understand individual and provider-level barriers and facilitators to cardiovascular disease management and prevention, and reduce the burden of cardiovascular diseases on vulnerable populations.
She has published 8 peer-reviewed journal articles and 10 conference abstracts (4 of them first-authored). These works have appeared in at least 3 highly ranked peer-reviewed journals, affirm the quality of her research, and are one of several factors that distinguish her from her peers.
Moreover, with a total of 27 citations to her published work, she has demonstrated the major impact of her original contributions in the field of public health.
Her research has been supported by funding from the National Institutes of Health (NIH). This funding is reserved solely for research directed at advancing the national interest, including studies aimed at furthering the knowledge of biological systems for the benefit of human health.
She has even received 2 letters of support from fellow experts in her field, out of those, one of the excerpts is mentioned below:

“…[client’s] skillset is irreplaceable, given its immense benefits to healthcare delivery, policy integration, and cardiovascular disease management. Her innovative strategies in the field of public health empower non-physician health workers and foster strategic partnerships, significantly improving healthcare outcomes for vulnerable populations. She must be allowed to carry out her research uninterrupted so that the United States fully benefits from its value.”

Her education, experience, expertise, documented record of success, influence in her field, and her plan have altogether well-positioned her to advance the proposed endeavor. We are pleased to celebrate her NIW approval, which, also thanks to Premium Processing, was granted in just 1 month and 22 days. It has been an honor to assist her, and we look forward to seeing the continued impact of her work in the future.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.